Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.960
+0.030 (1.55%)
At close: Oct 24, 2025, 4:00 PM EDT
1.920
-0.040 (-2.03%)
After-hours: Oct 24, 2025, 7:43 PM EDT
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $84.2 million as of October 24, 2025. Its market cap has decreased by -40.07% in one year.
Market Cap
84.20M
Enterprise Value
-24.62M
1-Year Change
-40.07%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $84.20M, a decrease of -91.10%. That is a compound annual growth rate of -36.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 84.20M | 51.20% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
| Jun 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.08B |
| Johnson & Johnson | 462.74B |
| AbbVie | 403.22B |
| UnitedHealth Group | 326.45B |
| AstraZeneca | 258.15B |
| Novartis AG | 254.23B |
| Novo Nordisk | 236.86B |
| Abbott Laboratories | 219.89B |